Compassionate use of drugs and medical devices in the United States, the European Union and Japan.

3 , there is not an increasing trend in FDA expanded access cases for drugs; however, Fig. 5 shows an increasing trend in FDA expanded access cases for vaccines, blood and biologics, as more regenerative therapy products, such as human cells and tissue products, enter the markets.

also in 63,971 other papers